金币
UID176556
帖子
主题
积分25192
注册时间2014-6-6
最后登录1970-1-1
听众
性别保密
|
欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
下文选自PIC/S
Companies should implement procedures that outline their policy and processes for the review of audit trails in accordance with risk management principles. Audit trails related to the production of each batch should be independently reviewed with all other records related to the batch and prior to the batch’s release, so as to ensure that critical data and changes to it are acceptable. This review should be performed by the originating department, and where necessary verified by the quality unit, e.g. during self-inspection or investigative activities.
Any significant variation from the expected outcome found during the audit trail review should be fully investigated and recorded. A procedure should describe the actions to be taken if a review of audit trails identifies serious issues that can impact the quality of the medicinal products.
The company’s Quality Unit (QU) should also review a sample of the audit trails records during the routine selfinspection.
|
|